» Articles » PMID: 19291777

The Phenotype of Persons Having Mosaicism for Trisomy 21/Down Syndrome Reflects the Percentage of Trisomic Cells Present in Different Tissues

Overview
Specialty Genetics
Date 2009 Mar 18
PMID 19291777
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Little is known about the pathogenesis of the phenotype in individuals with trisomy 21 mosaicism and Down syndrome. The primary goal of this study was to identify factors contributing to the observed phenotypic variation by evaluating 107 individuals having trisomy 21 mosaicism. To investigate a potential "threshold" effect due to trisomic imbalance, lymphocyte and buccal mucosa nuclei were scored using FISH. Overall, buccal cells showed a significantly higher frequency of trisomy than lymphocytes (P < 0.0001). Using latent class analysis, two phenotypic classes were identified based on the clinical findings of the propositi. Patients from class 1 had significantly fewer traits and a lower percentage of trisomic cells (mean of 37.3% lymphocytes; 34.5% buccal mucosa cells) when compared to those stratified into class 2 (54.0% lymphocytes; 53.4% buccal mucosa cells). Tissue-specific influences were also detected, with buccal mucosa trisomy levels being significantly correlated with IQ (P = 0.0094; both ectodermal derivatives), while congenital heart defects were significantly correlated with lymphocytes (P = 0.0286; both mesodermal embryonic derivatives). In conclusion, allowing for the distinction of two groups, we observed variation in phenotype, associated with the percentage of trisomic cells. We also observed tissue-specific effects on phenotype. The results of this study should enable geneticists and other health care professionals to provide information regarding optimal diagnostic approaches and anticipated clinical outcomes.

Citing Articles

A de novo, mosaic and complex chromosome 21 rearrangement causes APP triplication and familial autosomal dominant early onset Alzheimer disease.

Ehn E, Eisfeldt J, Laffita-Mesa J, Thonberg H, Schoumans J, Portaankorva A Sci Rep. 2025; 15(1):2912.

PMID: 39849058 PMC: 11759332. DOI: 10.1038/s41598-025-86645-0.


A personalized multi-platform assessment of somatic mosaicism in the human frontal cortex.

Zhou W, Mumm C, Gan Y, Switzenberg J, Wang J, De Oliveira P bioRxiv. 2025; .

PMID: 39763954 PMC: 11702624. DOI: 10.1101/2024.12.18.629274.


Neuropathology of trisomy 21 mosaicism in a case with early-onset dementia.

Ngo P, Pascual J, Wright S, Williams C, Magaki S, Yong W Alzheimers Dement. 2024; 21(1):e14394.

PMID: 39655579 PMC: 11772706. DOI: 10.1002/alz.14394.


Case Report: Atypical motor development in a patient with the mosaic form of Down syndrome and spinal muscular atrophy type 2- long-term observation.

Gajewska E, Flicinski J, Sobieska M, Michalska J, Zarowski M, Steinborn B Front Genet. 2024; 15:1483903.

PMID: 39649095 PMC: 11621056. DOI: 10.3389/fgene.2024.1483903.


The mTOR Pathway: A Common Link Between Alzheimer's Disease and Down Syndrome.

Wohlfert A, Phares J, Granholm A J Clin Med. 2024; 13(20).

PMID: 39458132 PMC: 11508835. DOI: 10.3390/jcm13206183.


References
1.
Taylor A . Further observations of cell selection in vivo in normal-G trisomic mosaics. Nature. 1970; 227(5254):163-4. DOI: 10.1038/227163a0. View

2.
Mikkelsen M . Down syndrome: cytogenetical epidemiology. Hereditas. 1977; 86(1):45-50. DOI: 10.1111/j.1601-5223.1977.tb01211.x. View

3.
Hamerton J, Giannelli F, POLANI P . CYTOGENETICS OF DOWN'S SYNDROME (MONGOLISM). I. DATA ON A CONSECUTIVE SERIES OF PATIENTS REFERRED FOR GENETIC COUNSELLING AND DIAGNOSIS. Cytogenetics. 1965; 4:171-85. DOI: 10.1159/000129853. View

4.
WUNSCH W . Some characteristics of mongoloids evaluated in a clinic for children with retarded mental development. Am J Ment Defic. 1957; 62(1):122-30. View

5.
Johnson R, Abelson R . Intellectual, behavioral, and physical characteristics associated with trisomy, translocation, and mosaic types of Down's syndrome. Am J Ment Defic. 1969; 73(6):852-5. View